Flagship Biosciences, Inc.
Flagship Biosciences, the pioneer of computational Tissue Analysis (cTA™), helps drug developers confidently define their path to success. By leveraging our unique cTA™ and Data-Driven-Decision Support Platform, we provide quantitative and contextual tissue interpretation that empowers clients to make confident and timely decisions. We are proud to have served over 100 pharma and biotech companies in oncology, immunology, and rare disease investigations. For more information on how we accelerate drug development, visit our website: www.flagshipbio.com, and follow us on twitter @FlagshipBio